Navigation Links
Syndax and Eddingpharm Enter into a License Agreement Giving Eddingpharm Rights to Commercialize Entinostat in China and Other Asian Countries
Date:9/4/2013

WALTHAM, Mass., Sept. 4, 2013 /PRNewswire/ -- Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers and Eddingpharm, a leading specialty pharmaceutical company in China, entered into a licensing, development and commercialization agreement that gives Eddingpharm exclusive rights to develop, market and sell entinostat in China and certain other Asian countries/regions. Financial details are undisclosed but include milestone payments and royalties on future entinostat sales. Details of the agreement include:

  • Eddingpharm receives exclusive rights to develop, market and sell entinostat in mainland China, Hong Kong, Thailand, Macau, Taiwan, Malaysia and Singapore
  • Eddingpharm receives rights to manufacture entinostat
  • Syndax will receive royalties on future entinostat sales
  • Eddingpharm may participate in entinostat's first three global Phase 3 registration trials
  • A joint development committee will oversee conduct of any trials
  • A joint commercialization committee will oversee marketing
  • Eddingpharm can explore further indications for entinostat in China
  • All data will be shared by both companies for regulatory purposes

"We look forward to working closely with Syndax to develop entinostat in breast and lung cancer as well as other indications," said Xin Ni, chairman and chief executive officer of Eddingpharm. "We are focused on bringing new and effective treatments to patients in our Asian communities
'/>"/>

SOURCE Syndax Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
2. Syndax Pharmaceuticals Announces Publication of Clinical Study Demonstrating that Entinostat Targets Resistance Pathways in Breast Cancer
3. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
4. Ruggles Family Foundation and Mr. and Mrs. Rudy L. Ruggles, Jr. Make $1.25M Donation to J. Craig Venter Institute for New Study to Identify and Elucidate Healthy Aging Biomarkers
5. Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction
6. Texas Childrens Hospital establishes the Jeffrey Modell Diagnostic & Research Center with a donation from the Jeffrey Modell Foundation
7. Fountain Valley Regional Medical Center Becomes Orange Countys First Hospital Awarded Advanced Certification In Inpatient Diabetes Care
8. Athens Regional Medical Center Boosts Patient Safety with Expanded Use of Capnography
9. CVS Caremark Hosts Grand Opening of State-of-the-Art Mail Service Pharmacy and Customer Center
10. INTERPHEX and Parenteral Drug Association Announce Agreement
11. Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015 Hospira, ... in the development of biosimilar therapies, spoke about the ... at the European Generics Association (EGA) annual European Biosimilars ... The company also announced the publication of a ... to achieving the full promise of biosimilars." ...
(Date:4/24/2015)... April 24, 2015  Blueprint Medicines today announced ... and potent inhibitor of fibroblast growth factor receptor ... of hepatocellular carcinoma (HCC) that are dependent on ... induced complete tumor regression in a subset of ... at the highest dose levels. These data will ...
(Date:4/23/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... monitoring, today reported net income for the quarter ended ... share.  Net income for the same period a year ... and non-GAAP net income was $82.1 million, or $0.76 ... quarter ended March 31, 2015 increased 13.0 percent to $590.3 ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
... March 9, 2011 Nearly half a million patients ... primary care physician offices patient-centered medical homes, thanks to ... that garnered participation from six health plans to improve ... The health plans--Aetna, CDPHP, Hudson Health Plan, MVP Health ...
... N.J., and LEIDEN, Netherlands, March 8, 2011 Johnson & ... Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today ... ( na-aanmeldingstermijn, Subsequent Offering Period), Johnson & Johnson has ... (which includes treasury shares held by Crucell) and 98.93% of ...
Cached Medicine Technology:Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents 2Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents 3Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents 4Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 2Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 3Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 4Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 5Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 6Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 7
(Date:4/24/2015)... 24, 2015 With years of experience ... is now proud to be partnered with a veterinary ... animals a year. This partnership has brought new payment ... , After providing an in-house payment plan for ... Hospital (VMTH) wanted to increase financing options available to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive ... & 2 suppliers, content providers, associations and government bodies. ... value chain, see them converge in Berlin. This year’s ... from those companies currently at the forefront of Europe’s ... on customer centric products, ParkTAG are one of the ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... forces are used worldwide, and how they would not be ... says that the nations have been trained to build up ... to the confusion and distrust. , “The nations believe ... forced compliance, unjust rules and laws, and the rape of ...
(Date:4/24/2015)... 2015 Recent research by the CareerBuilder ... therapists and their assistants are among the top 10 ... by the year 2023. , Physical therapists are ... growth and greatest potential for expansion in the future. ... that while physical therapists can offer great relief to ...
Breaking Medicine News(10 mins):Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2
... Surayud Chulanont, has defended his government's move to allow the ... of US worries over intellectual property rights in the kingdom. ... we can explain our action to other countries as well ... This Tuesday, Health Minister Mongkol Na Songkhla will be traveling ...
... old man that visits a doc, there is a woman; much like ... for success. ,Some Older men need to be goaded ... has revealed The woman could be a wife, daughter or even a ... of men above 50 years visit a doctor only after being coaxed ...
... is not funny. Infact their love for the spirits has ... by the fallout of the binge drinking culture on the ... trend evident among all age groups, class, boundaries and cultural ... Australia in the next 20 years. Many Australians will be ...
... over a long period of time may decrease brain volume, ... Academy of Neurology's 59th Annual Meeting in Boston, April ... MRI scans of 1,839 people from the Framingham Offspring study, ... drinkers, low drinkers (one to seven drinks per week), moderate ...
... cells that can repair the most severe damage to the ... lie around and do nothing, but when neighboring cells ... A report on the discovery will appear online next week ... cells act like the Army Reserves of our nose, explains ...
... of Rhode Island have demonstrated a new way to target ... protein that acts like a nanosyringe to deliver tags or ... of the National Academy of Sciences. ... (Low) Insertion Peptide) can be injected into the abdomen of ...
Cached Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2Health News:When Smell Cells Fail They Call In Stem Cell Reserves 2Health News:Novel Technology to Locate and Treat Tumors 2
Shandon Excelsior ES Tissue Processor continues the Thermo Electron Corporation tradition of offering one of the most advanced, traditional reagent instruments available today....
... Suds-Rite is our low-foaming detergent ... and other pressurized water units. ... of washer sterilizers, cart washers, bottle ... Highly concentrated, Suds-Rite removes blood and ...
... enzymatic detergent with three powerful active enzymes ... works to break down stubborn organic material ... residue. Dried blood, tissue, mucous, and other ... power of EndoTerg. Designed specifically for flexible ...
... for critical patients more waveforms, 12-Lead ... calculations package and cardiac output bundled ... transport with your patients., We use ... which means less time spent ...
Medicine Products: